Workflow
Halozyme to Report First Quarter 2025 Financial and Operating Results
HALOHalozyme(HALO) Prnewswire·2025-04-28 20:30

For more information visit www.halozyme.com and connect with us on LinkedIn and Twitter. About Halozyme Halozyme is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. As the innovators of ENHANZE® drug delivery technology with the proprietary enzyme rHuPH20, Halozyme's commercially-validated solution is used to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient e ...